Answers are grounded in this paper and cite their sources.
In 2017, the cardiology community celebrated the 40th anniversary of the first coronary angioplasty by Gruntzig in Zurich, Switzerland (1). During this period of time, percutaneous coronary intervention (PCI) rapidly progressed from plain balloon angioplasty to bare-metal and drug-eluting stent (DES) platforms, the latter being a first-line therapy for patients presenting with anatomically suitable obstructive disease of coronary arteries (2).
No takes yet. Share an insight, caveat, or question.
Cassese et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: